We are Abwiz Bio

Abwiz Bio was founded in September 2012 by two scientists in San Diego to address the quality issues of antibodies currently used in research.

Along with our strong selection strategies, our unique cloning method "WizAmpTM" enables us to obtain a wide range of antibodies that would otherwise have been missed by hybridoma technology or other phage display methods. Our fully-functional rabbit monoclonal antibodies developed from our "RabWizTM" technology have more diverse recognition of antigen epitopes with higher-specificity and higher-affinity than our competitors, facilitating reliable target detection. We have also developed a mouse and alpaca VHH recombinant antibody production and development platform using our phage technology.

We provide the highest quality monoclonal antibodies to the research reagent, clinical diagnostics, and therapeutics industries. We develop monoclonal antibodies and license and/or OEM our products to our customers, as well as help customers develop monoclonal antibodies as a contract research organization. Contact us today to see how our recombinant antibody production and development platform can help you achieve your goals.

Founders

DPP41

CJ Okumura, PhD, MBA

Chief Executive Officer and President
4U7B7856

Toshi Maruyama, MD, PhD

Chief Scientific Officer and Chief Operations Officer

Research team

headshot of Abwiz scientist Alex

Alex Samadi, PhD

Senior Scientist
headshot of Abwiz scientist Kevin

Kevin Entzminger, PhD

Director of Antibody Discovery and Engineering
headshot of Abwiz scientist Lisa

Lisa Espinosa

Associate Scientist II
headshot of Abwiz scientist Yasu

Yasu Kurosawa, PhD

Senior Scientist
headshot of Abwiz scientist Yukoh

Yuko Hiramoto

Research Technician